Delivery Order SPE2DB24D2018-SPE2DB26FWRN5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,187.06 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1/10 tablets (28-count packages) with a firm fixed price and no set-aside designation. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $4,455.71 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a competitive procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $37,032.75 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablet 28-count units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply...
- The Defense Logistics Agency awarded a $2,841.98 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packages) with a completion date of June 9, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $1,860.13 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) under a firm fixed price contract type. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, where the performance location is also based, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $2,396.04 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price, non-set-aside contract represents a pharmaceutical delivery under AmerisourceBergen's broader federal medical supply relationships. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,247.15 on July 21, 2025, for the supply of Lo Loestrin FE 1-10 tablets in 28-count packages. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office....
- The Defense Logistics Agency awarded a delivery order valued at $9,288.84 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) on June 4, 2025, with completion scheduled for June 5, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with performance based in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,398.34 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count package) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a supply of a brand-name oral contraceptive medication. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,943.58 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count packages. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a continuation of pharmaceutical procurement under the company's broader contractual relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB26FWRN5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,895.98 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages). This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on October 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location. This delivery order was issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, and specialty pharmaceuticals—to support military healthcare programs globally. The IDC serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning AmerisourceBergen Drug Corp as a critical vendor for federal medical procurement needs within the defense supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 10/27/25 |